Molecular and phenotypic heterogeneity of metastatic prostate cancer

Cindy H. Chau; William D. Figg

doi:10.4161/cbt.4.2.1571

Molecular and phenotypic heterogeneity of metastatic prostate cancer

Cindy H. Chau, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

4 Scopus citations

Abstract

Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this heterogeneity is essential in assessing therapeutic outcomes in the management of prostate cancer progression.

Original language	English
Pages (from-to)	174-175
Number of pages	2
Journal	Cancer Biology and Therapy
Volume	4
Issue number	2
DOIs	https://doi.org/10.4161/cbt.4.2.1571
State	Published - Feb 2005
Externally published	Yes

Keywords

Cancer
Heterogeneity
Metastasis
Phenotype
Prostate

Access to Document

10.4161/cbt.4.2.1571

Cite this

@article{cdd49196e5754f75834eb70ed4558f6d,

title = "Molecular and phenotypic heterogeneity of metastatic prostate cancer",

abstract = "Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this heterogeneity is essential in assessing therapeutic outcomes in the management of prostate cancer progression.",

keywords = "Cancer, Heterogeneity, Metastasis, Phenotype, Prostate",

author = "Chau, {Cindy H.} and Figg, {William D.}",

year = "2005",

month = feb,

doi = "10.4161/cbt.4.2.1571",

language = "English",

volume = "4",

pages = "174--175",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

number = "2",

}

TY - JOUR

T1 - Molecular and phenotypic heterogeneity of metastatic prostate cancer

AU - Chau, Cindy H.

AU - Figg, William D.

PY - 2005/2

Y1 - 2005/2

N2 - Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this heterogeneity is essential in assessing therapeutic outcomes in the management of prostate cancer progression.

AB - Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this heterogeneity is essential in assessing therapeutic outcomes in the management of prostate cancer progression.

KW - Cancer

KW - Heterogeneity

KW - Metastasis

KW - Phenotype

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=25144486652&partnerID=8YFLogxK

U2 - 10.4161/cbt.4.2.1571

DO - 10.4161/cbt.4.2.1571

M3 - Short survey

C2 - 15738648

AN - SCOPUS:25144486652

SN - 1538-4047

VL - 4

SP - 174

EP - 175

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

IS - 2

ER -

Molecular and phenotypic heterogeneity of metastatic prostate cancer

Abstract

Keywords

Access to Document

Fingerprint

Cite this